Joseph W Polli - JoVE Visualize

Showing results (11-20 of 51) with videos related to

Pageof 6

Sort By:

Biophysical Journal|October 27, 2004

The elementary mass action rate constants of P-gp transport for a confluent monolayer of MDCKII-hMDR1 cellsThuy Thanh Tran, Aditya Mittal, Tanya Aldinger, et al.

Journal of Pharmaceutical Sciences|September 7, 2004

In vitro absorption and secretory quotients: practical criteria derived from a study of 331 compounds to assess for the impact of P-glycoprotein-mediated efflux on drug candidatesVictoria E Thiel-Demby, Timothy K Tippin, Joan E Humphreys, et al.

British Journal of Clinical Pharmacology|September 29, 2025

Prediction of neutrophil nadir and recovery following paediatric haematopoietic cell transplantation with busulfan conditioningBeth Apsel Winger, Joseph W Polli, Janel Long-Boyle, et al.

Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 27, 2009

Use of cassette dosing in sandwich-cultured rat and human hepatocytes to identify drugs that inhibit bile acid transportKristina K Wolf, Sapana Vora, Lindsey O Webster, et al.

Journal of Pharmaceutical Sciences|July 6, 2004

Exact kinetic analysis of passive transport across a polarized confluent MDCK cell monolayer modeled as a single barrierThuy Thanh Tran, Aditya Mittal, Tracy Gales, et al.

Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 22, 2012

Evaluation of drug interactions of GSK1292263 (a GPR119 agonist) with statins: from in vitro data to clinical study designJoseph W Polli, Elizabeth Hussey, Mark Bush, et al.

BMC Pharmacology & Toxicology|May 2, 2013

Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitusElizabeth K Hussey, Anita Kapur, Robin O'Connor-Semmes, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 26, 2020

Predicting Volume of Distribution in Humans: Performance of In Silico Methods for a Large Set of Structurally Diverse Clinical CompoundsNeha Murad, Kishore K Pasikanti, Benjamin D Madej, et al.

Chemical Research in Toxicology|December 12, 2012

Central nervous system disposition and metabolism of Fosdevirine (GSK2248761), a non-nucleoside reverse transcriptase inhibitor: an LC-MS and Matrix-assisted laser desorption/ionization imaging MS investigation into central nervous system toxicityStephen Castellino, M Reid Groseclose, James Sigafoos, et al.

Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 5, 2015

Drug interaction profile of the HIV integrase inhibitor cabotegravir: assessment from in vitro studies and a clinical investigation with midazolamMelinda J Reese, Gary D Bowers, Joan E Humphreys, et al.

Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:

Pageof 6

Biophysical Journal|October 27, 2004

The elementary mass action rate constants of P-gp transport for a confluent monolayer of MDCKII-hMDR1 cellsThuy Thanh Tran, Aditya Mittal, Tanya Aldinger, et al.

Journal of Pharmaceutical Sciences|September 7, 2004

In vitro absorption and secretory quotients: practical criteria derived from a study of 331 compounds to assess for the impact of P-glycoprotein-mediated efflux on drug candidatesVictoria E Thiel-Demby, Timothy K Tippin, Joan E Humphreys, et al.

British Journal of Clinical Pharmacology|September 29, 2025

Prediction of neutrophil nadir and recovery following paediatric haematopoietic cell transplantation with busulfan conditioningBeth Apsel Winger, Joseph W Polli, Janel Long-Boyle, et al.

Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 27, 2009

Use of cassette dosing in sandwich-cultured rat and human hepatocytes to identify drugs that inhibit bile acid transportKristina K Wolf, Sapana Vora, Lindsey O Webster, et al.

Journal of Pharmaceutical Sciences|July 6, 2004

Exact kinetic analysis of passive transport across a polarized confluent MDCK cell monolayer modeled as a single barrierThuy Thanh Tran, Aditya Mittal, Tracy Gales, et al.

Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 22, 2012

Evaluation of drug interactions of GSK1292263 (a GPR119 agonist) with statins: from in vitro data to clinical study designJoseph W Polli, Elizabeth Hussey, Mark Bush, et al.

BMC Pharmacology & Toxicology|May 2, 2013

Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitusElizabeth K Hussey, Anita Kapur, Robin O'Connor-Semmes, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 26, 2020

Predicting Volume of Distribution in Humans: Performance of In Silico Methods for a Large Set of Structurally Diverse Clinical CompoundsNeha Murad, Kishore K Pasikanti, Benjamin D Madej, et al.

Chemical Research in Toxicology|December 12, 2012

Central nervous system disposition and metabolism of Fosdevirine (GSK2248761), a non-nucleoside reverse transcriptase inhibitor: an LC-MS and Matrix-assisted laser desorption/ionization imaging MS investigation into central nervous system toxicityStephen Castellino, M Reid Groseclose, James Sigafoos, et al.

Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 5, 2015

Drug interaction profile of the HIV integrase inhibitor cabotegravir: assessment from in vitro studies and a clinical investigation with midazolamMelinda J Reese, Gary D Bowers, Joan E Humphreys, et al.

Pageof 6